Skip to main content

A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular

Submitted by rachel on Mon, 07/22/2024 - 18:03
  • Read more about A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Submitted by rachel on Mon, 07/22/2024 - 18:03
  • Read more about Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Submitted by rachel on Mon, 07/22/2024 - 18:03
  • Read more about Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Submitted by rachel on Mon, 07/22/2024 - 18:02
  • Read more about The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Submitted by rachel on Tue, 05/07/2024 - 13:56
  • Read more about A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis

Submitted by rachel on Tue, 05/07/2024 - 13:56
  • Read more about A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis

A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Submitted by rachel on Tue, 05/07/2024 - 13:56
  • Read more about A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia

Submitted by rachel on Tue, 05/07/2024 - 13:56
  • Read more about Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Submitted by rachel on Tue, 05/07/2024 - 13:56
  • Read more about Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

US Selumetinib Registry

Submitted by rachel on Tue, 05/07/2024 - 13:55
  • Read more about US Selumetinib Registry

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • …
  • Next page Next
  • Last page Last
Subscribe to